Navigation Links
Haemonetics Reports First Quarter Fiscal 2013 Results, Completes Acquisition of Pall's Transfusion Medicine Business, Affirms Fiscal 2013 Earnings Guidance, Provides Preliminary Outlook for Fiscal 2014 and Announces Share Repurchase
Date:8/1/2012

/p>

% Consolidated Balance Sheets(Unaudited data in thousands)As of6/30/20123/31/2012AssetsCash and cash equivalents

$

236,047$

228,861Accounts receivable, net

126,130135,464Inventories, net

126,843117,163Other current assets

51,16745,641Total current assets

540,187527,129Net PP&E

166,240161,657Other assets

221,696222,349Total assets$928,123$911,135As of6/30/20123/31/2012Liabilities & Stockholders' EquityShort term debt & current maturities

$

2,417$

894Other current liabilities

119,489129,850Total current liabilities

121,906130,744Long-term debt

2,6422,877Other long-term liabilities

46,10844,883Stockholders' equity

757,467732,631Total liabilities & stockholders' equity$928,123$911,135 Free Cash Flow Reconciliation(Unaudited data in thousands)Three Months Ended6/30/20127/2/2011GAAP cash flow from operations

$

553$

27,131Capital expenditures

(8,441)(11,801)Proceeds from sale of property, plant and equipment

25219Net investment in property, plant and equipment

(8,189)(11,782)Free cash flow after restructuring and transformation costs

(7,636)15,349Restructuring and transformation costs

10,7451,778Free cash flow before restructuring and transformation costs$3,109$17,127Haemonetics Corporation Financial SummaryReconciliation of Non-GAAP MeasuresHaemonetics has presented supplemental non-GAAP financial measures as part of this earnings release. A reconciliation is provided below that reconciles each non-GAAP financial measure with the most comparable GAAP measure. The presentation of non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the most directly comparable GAAP measures. There are material limitations to the usefulness of non-GAAP measures on a standa
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
2. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
3. Interleukin Genetics Reports Third Quarter 2011 Financial Results
4. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
5. Nile Therapeutics Reports 2011 Third Quarter Financial Results
6. Pharmasset Reports Fiscal Year End 2011 Financial Results
7. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
8. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
9. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
10. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
11. Biodel Reports Fourth Quarter Fiscal Year 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... HILLS, Calif. , May 23, 2013  Saddleback ... recently became the first hospital on the ... robotic technology. This new surgical option provides women with ... Marc Winter , M.D., ... gynecologist and surgeon and medical director of minimally invasive ...
(Date:5/23/2013)... 2013 Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced ... year,s American Society Of Clinical Oncology (ASCO) meeting in ... role in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ... the pre-eminent conference focused on clinical treatment of cancer, ...
(Date:5/23/2013)... 2013 Pusan National University Yangsan Hospital, ... and contract research company focused on research and ... today a publication reporting the induction of functional ... and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; Jennerex Inc.). ... the May 15 th , 2013 issue of ...
(Date:5/23/2013)... 2013 Watlow®, an industry leader ... systems, recently introduced its new catalog, Watlow® Heating ... in designing and manufacturing industrial heaters, Watlow provides ... serve diverse customer needs. , A description of ... beginning of the book. These options allow high ...
Breaking Biology Technology:Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3Watlow Introduces Its New Industrial Heater Catalog 2
... Dec. 11 Myngle,( http://www.myngle.com ), the global ... ICT company at the Europe Unlimited,s European Venture ... EVS is a showcase for ... and new energy entrepreneurs from all over Europe ...
... Inc. (Nasdaq: PBIO ) ("PBI" or the ... have entered into a strategic marketing, distribution, and technology ... companies will: (1) share market data, customer leads, technology ... industry trade shows beginning in 2009; (3) license Omni ...
... HAMBURG, Germany, December 11 Olympus has further,cemented its ... invasive surgery,by signing an exclusive and immediate deal to ... ASC is the sole global,provider of ports for state-of-the-art ... patient,s navel. Olympus is now the exclusive,distributor for the ...
Cached Biology Technology:Myngle Best ICT Company at the European Ventures Summit 2Pressure BioSciences, Inc. and Omni International Announce Marketing, Distribution, and Technology Development Agreement 2Pressure BioSciences, Inc. and Omni International Announce Marketing, Distribution, and Technology Development Agreement 3Pressure BioSciences, Inc. and Omni International Announce Marketing, Distribution, and Technology Development Agreement 4Pressure BioSciences, Inc. and Omni International Announce Marketing, Distribution, and Technology Development Agreement 5Minimally Invasive Surgery: Olympus Further Enhances Credentials by Entering Into Exclusive Sales and Distribution Partnership With Market and Technology Leader Advanced Surgical Concepts 2
(Date:5/22/2013)... to genetic engineering drastically reduces the time and ... the workhorses of biotechnology, scientists are reporting. Published ... the method paves the way for more rapid ... cleanup and other activities. , Keith Shearwin and ... of the genetic material DNA into a bacterium,s ...
(Date:5/22/2013)... Irvine, Calif., May 22, 2013 Early screening for ... personal pregnancy testing is for women, thanks to UC ... the American Chemical Society . , After more than ... a way to clearly identify clinically usable markers for ... be detected far sooner, with greater accuracy and at ...
(Date:5/21/2013)... increasingly being considered in the management of natural ... that can help them recognize and respond to ... their lives. , Place-Based Conservation: Perspectives from ... the Pacific Northwest Research Station,s Linda Kruger, can ... The book is published by Springer Verlag and ...
Breaking Biology News(10 mins):UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3
... at the University of Pennsylvania School of Medicine have ... a vaccine used to study HIV in macaque monkeys ... (SHIV) than an unmodified vaccine. This multi-year study found ... boosts the effects of a vaccine derived from the ...
... of lead in children,s blood -- amounts well below ... IQ scores, finds a new six-year Cornell study., The ... function in children whose blood-lead levels (BLLs) were below ... of 10 micrograms per deciliter (mcg/dl) -- about 100 ...
... --- Driving down a country road at night your cars ... doesnt move. Depending on your speed and other conditions, chances ... do, its because you are in what is fittingly defined ... published online Nov. 13 by the journal PLoS Biology. ...
Cached Biology News:Penn researchers find monkeys able to fend off AIDS-like symptoms with enhanced HIV vaccine 2Even minute levels of lead cause brain damage in children 2Northwestern study looks at sensing, movement and behavior 2Northwestern study looks at sensing, movement and behavior 3
This buffer is Specifically formulated to be used with Endogen's Poly-HRP Streptavidin...
... The Microarray Gene Frame® has ... hybridisations. These frames feature the same ... standard Gene Frame® range for easy ... hybridisation uniformity and there are three ...
For microscopy...
... Fully automated microarray slide processing ... The trend to miniaturization, automation ... technology a powerful tool with many ... settings. These applications range from gene ...
Biology Products: